Evidence map›Paper›PMID 29572520›Full record

ArticleScientific reports2018

Altered Insulin/Insulin-Like Growth Factor Signaling in a Comorbid Rat model of Ischemia and β-Amyloid Toxicity.

Zareen Amtul, David J Hill, Edith J Arany, David F Cechetto

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Rodent Models of Post-Stroke Dementia.International journal of molecular sciences · 2022
    Review
  4. BACE1: More than just a β-secretase.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zareen AmtulDepartment of Anatomy and Cell Biology, University of Western Ontario, London, N6A 5C1, Canada. zareen.amtul@gmail.com.
David J HillDepartments of Medicine, Physiology and Pharmacology, and Pediatrics, University of Western Ontario, London, N6A 5C1, Canada.
Edith J AranyDepartment of Pathology and Laboratory Medicine, University of Western Ontario, London, N6A 5C1, Canada.
David F CechettoDepartment of Anatomy and Cell Biology, University of Western Ontario, London, N6A 5C1, Canada.
Western University · CALawson Health Research Institute · CA

Funding

CIHR R1478A47
6 · The paper itself

Abstract

Ischemic stroke and diabetes are vascular risk factors for the development of impaired memory such as dementia and/or Alzheimer's disease. Clinical studies have demonstrated that minor striatal ischemic lesions in combination with β-amyloid (Aβ) load are critical in generating cognitive deficits. These cognitive deficits are likely to be associated with impaired insulin signaling. In this study, we examined the histological presence of insulin-like growth factor-I (IGF-1) and insulin receptor substrate (IRS-1) in anatomically distinct brain circuits compared with morphological brain damage in a co-morbid rat model of striatal ischemia (ET1) and Aβ toxicity. The results demonstrated a rapid increase in the presence of IGF-1 and IRS-1 immunoreactive cells in Aβ + ET1 rats, mainly in the ipsilateral striatum and distant regions with synaptic links to the striatal lesion. These regions included subcortical white matter, motor cortex, thalamus, dentate gyrus, septohippocampal nucleus, periventricular region and horizontal diagonal band of Broca in the basal forebrain. The alteration in IGF-1 and IRS-1 presence induced by ET1 or Aβ rats alone was not severe enough to affect the entire brain circuit. Understanding the causal or etiologic interaction between insulin and IGF signaling and co-morbidity after ischemia and Aβ toxicity will help design more effective therapeutics.

Indexed as

Signal TransductionAmyloid beta-PeptidesAnimalsBrain IschemiaCognition DisordersComorbidityCorpus StriatumDisease Models, AnimalInsulinInsulin-Like Growth Factor IInsulin Receptor Substrate ProteinsMaleMemory DisordersRatsRats, WistarAmyloid beta-PeptidesInsulininsulin-like growth factor-1, ratInsulin-Like Growth Factor IInsulin Receptor Substrate ProteinsIrs1 protein, rat

Identifiers

PMID29572520
PMCPMC5865153
OpenAlexW2806680184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.